Market revenue in 2023 | USD 169.3 million |
Market revenue in 2030 | USD 244.0 million |
Growth rate | 5.4% (CAGR from 2023 to 2030) |
Largest segment | Accu-chek inform ii |
Fastest growing segment | Freestyle Lite |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Accu Check Aviva Meter, Onetouch Verio Flex, I-STAT, Freestyle Lite, Bayer CONTOUR blood glucose monitoring system, True Metrix, Accu-Chek Inform II, StatStrip |
Key market players worldwide | Roche, Abbott Laboratories, Nipro Corp, Nova Biomedical, ACON Laboratories, Bayer AG, EKF Diagnostics Holdings PLC |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 19.67% in 2023. Horizon Databook has segmented the China point-of-care glucose testing market based on accu check aviva meter, onetouch verio flex, i-stat, freestyle lite, bayer contour blood glucose monitoring system, true metrix, accu-chek inform ii, statstrip covering the revenue growth of each sub-segment from 2018 to 2030.
China is projected to have the world’s largest diabetic population owing to rapid rise in incidence of the disease. In addition, rise in the prevalence of infectious diseases and lifestyle disorders, including cardiovascular diseases, is expected to boost the adoption of POC glucose testing devices, thereby positively impacting the market growth.
Presence of a large number of local POC glucose testing product manufacturers has been a key factor contributing to the revenue generated by China in Asia Pacific POC glucose testing market.
Horizon Databook provides a detailed overview of country-level data and insights on the China point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into China point-of-care glucose testing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account